CeGaT Genetic Laboratory

CeGaT GmbH is Europe's largest company in clinical genetics, based in Tübingen — one of Germany's most distinguished university cities. Founded by Dr. Saskia Bishop, MD, a researcher and bioinformatician who has received numerous international awards for genetic research in Parkinson's disease, CeGaT has grown to serve physicians, patients, and pharmaceutical companies across Europe and beyond. With affiliates in Chicago (USA) and Beijing (China), CeGaT operates as a globally connected reference genetics laboratory. The Tübingen headquarters is home to Europe's most comprehensive portfolio of clinical genetic tests — more than 200 types of genetic and transcriptomic analyses spanning all major medical disciplines. CeGaT specialises in identifying genetic causes of rare diseases, hereditary cancer syndromes, somatic cancer mutations (tumour genomics), neurological genetic disorders (including epilepsy, ataxia, and intellectual disability), ophthalmological genetic conditions, cardiogenetics, and reproductive genetics (including carrier screening and preimplantation genetic testing). The laboratory uses state-of-the-art next-generation sequencing (NGS) platforms including the PacBio Sequel IIe long-read sequencer, enabling highly accurate whole genome sequencing, whole exome sequencing, gene panels, and RNA sequencing. CeGaT's bioinformatics pipeline and clinical interpretation team provide clinically actionable reports to referring physicians worldwide. For pharmaceutical companies, CeGaT provides genetic biomarker analysis for clinical trials and companion diagnostic development — a unique combination of clinical and translational genetics capabilities under one roof. Patients and physicians can order tests online, and CeGaT actively re-evaluates and updates genetic interpretations as the scientific evidence evolves.